Allotransplantation of vascularized composite tissue is a new field of transplantation surgery. One application of this technique is abdominal wall transplantation used as a supplementary procedure to the transplantation of visceral organs in patients with abdominal compartment deficits. As abdominal wall closure problems are experienced in around 30-40% of such patients, peer reviewed conclusions on the viability of various options, are important for an informed choice of possible procedures. This review focuses on the abdominal wall allotransplantion procedure. Our search provided 35 appropriate references which we used to support our findings as follows: abdominal wall transplantation was performed in 33 patients at seven centres. Of these, 30 had a full thickness abdominal wall transplanted from the same donor, 3 from a second donor. Three had visceral organ transplants and in addition, the posterior sheet of the rectus muscle fascia. In summary, our findings were that abdominal wall allotransplantation does not jeopardize the outcome of visceral organs transplantation. There is no higher risk of complications or rejection of the visceral organs. There have been no fatalities as a direct result of complications due to abdominal wall transplantation. Finally, the transplanted abdominal wall may provide an early warning of rejection before diagnostic tests on the bowel are symptomatic.
INTRODUCTION
Damage to or complete loss of the abdominal wall (AW) due to injury, tumours or after repeated surgery and its complications, endangers the vitality and integrity of the visceral organs (VO). Damage also occurs when there is loss of the greater part of the VO with retraction of the AW and reduction of the intra-abdominal compartment. Additionally, visceral organ allotransplantation (VOA) may be accompanied by failure of the AW to close and sometimes VOA cannot be performed at all. Approximately 30-40% of patients with intestinal allotransplantation (IA) may experience this problem 1, 2 . There are various methods available for AW closure where there is a discrepancy between the volume of the transplanted organs and the intra-abdominal space: Remedial techniques include reduction of the transplanted organs, splenectomy and/or selection of a donor smaller than the recipient: Expansion techniques include sequential transplantation, peritoneal expansion and use of tissue expanders.
For reconstruction and substitution, component separation, skin only suturing, sequential closure and an open abdomen with skin transplantation can be used. This also includes the use of flaps, synthetic meshes or skin replacements [1] [2] [3] [4] . If these options are exhausted, the remaining alternative is abdominal wall allotransplantation (AWA) (ref. [5] [6] [7] [8] ). To date, the reason for all AWAs was insufficient recipient abdominal wall tissue after a VOA. This review focuses on the results of AWA.
RESULTS
There were a total of 1874 hits with the key words chosen. Of these 1810 were eliminated on the basis of relevance. Of the remaining 64, 29 more were excluded due to duplication or peripheral topic and one was dropped as the paper had been retracted from publication. This left us with 35 valid articles on which to base this review.
Classification of the AW as a transplant
The AW from the plastic surgery perspective is a vascularized musculo-fascio-adipo-cutaneous flap. It contains peritoneum, muscles with fascia, fatty tissue and skin. It is transplanted as a discrete organ with its vascular supply. From the transplantation surgery perspective, it is classified as a "Vascularized Composite Allotransplant" (VCA) similar to a hand or face transplant.
In the United Network for Organ Sharing (UNOS) registry (USA), VCA was added to the list in July 2014 and there are nine criteria which must be fulfilled; 1. tissue is vascularized and requires connection of vessels for its vitality and functionality 2. it contains several types of tissues 3. it is obtained from a living donor as an anatomicalstructural unit 4. it is transplanted to a human recipient as an anatomical-structural unit 5. there is minimal tissue manipulation 6. it is used for homologous replacement 7. it is not combined with an artificial device 8. it can only be stored for a limited time 9. it requires immunosuppressive therapy 9
AWA in animal experiments
AWA is technically possible on a unilateral vascular system and with sufficient immunosuppressive therapy (IT) long term survival without rejection is possible 10, 11 . It has been found that longer term survival of both grafts can be achieved using a combination of AWA with vascularized bone marrow transplantation 12 . It is noted that anastomosis of the lower epigastric vessels bilaterally ensures perfusion of the whole transplant while partial ischemia may occur in unilateral anastomosis. AWAs involve a greater area of skin than facial transplantation, however chimerism is higher in face transplantation, probably due to a greater content of lymphatic tissue 13, 14 . After an AWA without any reconstruction of the nerves, there is significantly reduced muscle mass, myofibril cross-sectional area and reinervation 15 .
AWA in human cadaver dissection studies
Studies have examined the extent of perfusion of the AW resulting from alternatively the deep inferior epigastric artery or the common stem of the external iliac artery with the deep inferior epigastric artery, the deep circumflex iliac artery, the superficial epigastric artery and the superficial circumflex iliac artery. It was found that the deep circumflex iliac artery significantly improves perfusion of the lateral part of the AW (ref. 16 ). Innervation of the AW is provided by thoracolumbar nerves Th7-L4. It is possible to dissect 3-6 nerves that are 6-7 cm long with a diameter of approximately 2 mm (ref. 17, 18 ). After denervation of the AW there is a significantly reduced muscle tension strength, reduced muscle thickness and diameter of muscle fibres 19 . It was noted that innervation of the AW for sensory purposes was not essential as encapsulating the VOA was its primary purpose. However, one case report described a burn injury of the AWA after clinical transplantation as a result of skin hypesthesia 20 .
AWA in clinical practice
AWA was performed for the first time in 2001 in the USA, in nine patients in association with VOA. Vascular anastomoses were carried out macroscopically to the common iliac vessels, in three cases to the aorta and the inferior vena cava. Twice the AWA was performed as a delayed procedure from another donor. Two and a half years after transplantation, four patients survived. Three died due to sepsis, one due to bowel rejection and one due to primary bowel dysfunction. The AW had to be removed twice due to ischemia. In one case secondary healing occurred. In the second case the AW re-transplantation was performed successfully but the patient died due to sepsis. There were two cases of isolated rejection of the bowel and two cases of isolated rejection of the AW, always in patients who had the AWA from a separate donor [21] [22] [23] . The microsurgical technique of AWA was first carried out in Italy in 2007 in three patients. Anastomoses were performed between the deep inferior epigastric vessels bilaterally in two cases. In one case, only the unilateral vascular pedicle was used but it was successful, with no signs of ischemia. The AW healed in all three patients without rejection. Bowel rejection occurred in two patients. One patient died one year after transplantation due to post-transplant lymphoprolipherative disease (PTLD) the other two patients survived 24 . One patient had a recurrent episode of acute graft versus host disease (GVHD) however this was successfully treated with extracorporeal photopheresis and steroids 25 . A review article from 2009 evaluated the results of both the previous teams with post-surgery observation extending for 2-7 years 8 . Five of fourteen patients survived. None of the patients had died due to direct complications associated with AWA.
Another AWA with VOA was performed in Indianapolis in a young woman who had juvenile dermatomyositis. The VOA was temporarily covered with silastic mesh and the following day, an AWA was carried out with tissue from another donor. Anastomoses were performed utilising femoral vessels 26 . It was surmised in two reports that simultaneously performing VOA and an AWA where anastomosis of the AWA are done after the VOA is completed, increases the time of AWA ischemia with an increased risk of a subsequent acute rejection of both grafts or shorter graft survival 27, 28 . The transplantation strategy was subsequently modified in Oxford and the AW was temporarily vascularized with an anastomosis to the forearm vessels in six patients. After completion of the VOA, the overall condition of the patient and vessels in the pelvic area were evaluated. In favourable cases, the AW was disconnected from forearm vessels and attached with anastomosis of the epigastric vessels to the pelvic vessels of the recipient at the end of surgery. One patient revealed signs of hemodynamic instability after IA and the AW was not disconnected from the forearm. In one patient, ischemia of the AW occurred after anastomoses to the pelvic vessels, and connection to the forearm vessels was restored. Four weeks later the AW was disconnected from the forearm vessels in both latter patients. Supportive perfusion was carried out by anastomoses between upper epigastric vessels. Isolated rejection of the AW was diagnosed in three patients. In two patients a second episode occurred, in one case with bowel rejection. One patient developed GVHD. Six months after transplantation five patients survived, one patient died due to sepsis [29] [30] [31] [32] [33] . Another study compared a group of 15 patients with VOA and a group of 14 patients with simultaneous VOA and AWA from the same donor. Survival was similar in both groups and the differences were not significant. However, comparing the frequency and duration of repeated hospitalisation, better results were obtained in patients with simultaneous transplantations. Rejection of the AW occurred in 5 patients. Four of these re-attended two days after the first signs of rejection and histological examination revealed rejection of the AW only. The fifth patient presented after a week of persistent diarrhoea. Histology revealed both rejection of the AW and also the transplanted intestine. Four patients had GVHD. Absence of generalized skin exanthema on the AW skin helped with the diagnosis in both patients with AWA. The authors concluded that simultaneous AWA and VOA offers four advantages. (a) It is possible to perform a comfortable closure of the AW; (b) the skin of the AW may be used as an early marker of intestinal rejection; (c) it can help to clarify GVHD and (d) it can be useful for differential diagnosis between intestinal inflammation and rejection 34, 35 . Haveman et al. have reported one case of AWA carried out in conjunction with IA in a patient with ultra-short bowel syndrome as a result of Crohn's disease. At the time of reference the patient had survived for six months 36 . The AW may also be transplanted in a form of a split graft where only some layers are utilised. Three paediatric patients underwent liver transplantation together with the posterior fascia of the rectus abdominis muscles. The posterior fascia was connected with the liver by the falciform ligament, which contains nutritive vessels. The fascia remained vital with no signs of rejection. One patient died 51 days after the procedure due to sepsis, two having survived for 4 and 16 months at the time of reporting 37, 38 . Use of a non-vascularized fascia -Abdominal Wall nonVascularized non-Composite Allograft -was described in two studies. Healing in patients was reported as favourable, however exchange for a synthetic mesh or a new fascia was necessary in some cases. Despite the higher incidence of wound infection, there was no correlation with the failure rate of the procedure 39, 40 .
The selection of donor for AWA
The criteria for AW donors are similar to those for VO donors and have to comply with the legal regulations of the particular country where the procedure is performed. Age limits are not given; more important is the biological vitality of the tissue. Obese donors (Body Mass Index -BMI more than 30) should be excluded as well as donors with a serious injury to the abdominal wall or excessive scaring from previous abdominal procedures. From an aesthetic viewpoint, it is advisable to choose donors of similar skin and hair colour, weight and musculature but due to the seriousness of the condition and the limited pool of donors this is not always possible. Some recipients may also have psychological issues over receiving an abdominal wall that is extensively tattooed and/or decorated with multiple piercings.
Immunosuppressive therapy in clinical AWA
The immunosuppressive regimen in AWA is similar to that used in other VCA or organ transplantation procedures. Induction immunosuppression usually starts with alemtuzumab or daclizumab 8, 21, 24, 30, 34 . Maintenance immunosuppression is usually a combination of tacrolimus, mycophenolate mofetyl and prednisone. Sometimes only tacrolimus with corticosteroids is used 8, 21, 30 or even monotherapy with tacrolimus 21, 24, 34 . For rejection periods, boluses of corticosteroids are effective with or without increasing the dose of other immunosupressants. In the case of GVHD, boluses of corticosteroids are efficacious as well. For persistent episodes, extracorporeal photophoresis can be used with good result 25 .
Rejection of the AW
All foreign human tissues cause a reaction of the recipient immune system to a different degree of antigenicity and are subject to rejection by various mechanisms. There is a rejection ladder that has been proposed for individual tissues. Skin is highest followed by bone marrow, subcutaneous tissue, bone and then muscle. Low immunogenicity is a feature of vessels, tendons, cartilage and nerves. VCA, as a complex organ, triggers milder rejection than its individual tissue groups transplanted separately 41, 42 . The difference in tissue immunogenicity may also manifest as a split tolerance phenomenon. Here, one tissue class of VCA may be tolerated while another is rejected 43 . This phenomenon was demonstrated experimentally where it was shown that the skin of a limb was rejected while other tissues remained viable 44 . Split tolerance has also been confirmed in clinical practise in patients with a transplanted hand (from France, Austria and China) (ref. 45 ).
The AW skin rejection and its classification
Currently it is recommended that we use a scoring system, which was developed in consensus at a VCA symposium in 2007. (Banff's Scoring System -BSS). The BSS expresses severity of rejection and enables observation of its development (Table 1 .) (ref. 46 ).
Visual changes of the skin were not classified at this symposium due to their variability and diversity. However considering the potential clinical significance we note here the grading of histological stages with visual changes as reported by Kanitakis in 2007 (Table 2 .) (ref. 47 ).
Skin of AWA as a marker of VOA rejection
Skin is a primary target for rejection. It is also readily available for visual examination, so signs of acute rejection may be detected early without the need of biopsy or laboratory tests. It follows logically, that skin could be used as an early marker of a possible rejection event to the whole VCA and/or VOA. Experimental transplantation of limbs in combination with skin grafts have confirmed this hypothesis. Visual and histological signs of rejection manifested significantly earlier on a simplex skin graft than on a limb as a complex allograft 48 . Further, two clinical studies described simultaneous transplantation of a skin graft and a kidney. The skin graft was used as a marker of rejection but it was found that the survival of both grafts was the same 49, 50 . An Italian team used the skin graft as a marker of rejection in a clinical transplantation of a hand. Rejection in all patients manifested first on the skin graft prior to that of the transplanted hand 51 . There was however no difference in the onset of rejection between transplanted grafts when facial transplantation was performed in combination with vascularized forearm skin flap transplantation 52 .The reason may be that a vascularized skin flap is composed of similar tissues to that of a facial allograft.
In simultaneous AWA and IA, it is difficult to decide which graft represents a greater immunological burden. Bowel mucosa has similar immunogenicity to skin and the differences in onset of rejection in skin and bowel may be insignificant 53, 54 . In patients from Miami isolated rejection of the bowel was found twice and isolated rejection of the AW, twice as well 21, 55 . In patients from Bologna rejection of the bowel occurred twice but no rejection of the AW occurred 24 . Authors from Oxford reported isolated rejection of the AW four times and rejection of the AW simultaneously with the bowel only once 7, 29, 34, 56 . Current experiences show that AWA and IA may behave independently with regards to rejection. Their rejection occurs at approximately the same frequency and often as isolated events. It is reasonable to conclude that: (a) rejection of the skin in an AWA procedure does not always precede rejection of the VOA: (b) in cases where there is rejection of the skin, organ rejection may not necessarily follow.
CONCLUSION
According to the currently available literature, AWA has been performed in seven centres on 33 patients. Full thickness abdominal wall was transferred in 30 patients with restoration of circulation by vascular anastomoses between the vessels of the graft and the recipient. In 3 patients only the posterior sheet of the rectus muscles fascia was transferred with circulation provided by the vessels of the falciform ligament associated with liver transplantation. In 30 patients, AWA and VOA were from the same donor, in 3 patients from another.
The goal of AWA performed to date was to secure safe closure of the AW after the VOA. This was a "necessary for survival" secondary procedure and for this reason, there was no ethical consideration, such as may occur with transplantations of other VCAs (e.g. hand or face), where it introduces a significant lifelong risk of immunosuppressive therapy from a procedure that just serves to improve the quality of life. Harvesting of the AW does not endanger harvesting of other organs, because they have different vascular supplies. Simultaneous AWA and VOA extend the procedure by approximately two hours. The AW may be transferred using macroscopic or microscopic techniques on the iliac, femoral or deep inferior epigastric vessels. Transplantation of the AW may be delayed if needed and performed using tissue from a second donor. There is no need for rehabilitation, because to date, the function of the graft is only to seal the abdomen.
AWA is to date only indicated in patients with a seriously insufficient abdominal compartment, necessitating VOA. Indications may be extended in future to patients with, for example, extensive abdominal hernias, abdominal injuries or maybe congenital malformancies. In the event of such cases it will be necessary to modify the surgical technique to achieve sensory and motor reinnervation of the AW.
Search strategy and selection criteria
We carried out a literature search for the period from 1990-2017 using the bibliography of the databases: Pubmed, SCOPUS, Web of Science and Google Scholar. Search terms included: abdominal wall transplantation and abdominal wall allotransplantation. Since these procedures are specialised and publications on this issue are rare, the initial exclusion criteria were narrow. To encompass more data, we also used abstracts and poster references. The exclusion criteria were (a) duplicate references, (b) references where AWA was peripheral to the topic and (c) invalid or irrelevant references.
